Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001193125-25-314742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-12-10 | 2025-12-08 | WVE | Rawcliffe Adrian | Dir | S - Sale+OE | $15.00 | -42.0K | 12.7K | -77% | -$630.0K |
| DT | 2025-12-10 | 2025-12-08 | WVE | Rawcliffe Adrian | Dir | M - OptEx | $5.97 | +42.0K | 54.7K | +331% | +$250.7K |
| DT | 2025-12-10 | 2025-12-08 | WVE | Rawcliffe Adrian | Dir | M - OptEx | $0.00 | -42.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-12-08 | S | D | 42,000 | $15.00 | 12,700 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-12-08 | M | A | 42,000 | $5.97 | 54,700 | D | — | — | |
| 3 | Derivative | Share Option (right to buy) | 2025-12-08 | M | D | 42,000 | $0.00 | 0 | D | $5.97 · — to 2026-08-16 | 42,000 Ordinary Shares | (F2) These share options are fully vested. |